Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Cash & Equivalents (2020 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Cash & Equivalents came in at $41.5 million in Q1 2026, up 3760.12% YoY from $1.1 million in Q1 2025, and up 143.84% on a QoQ basis from $17.0 million in Q4 2025.

Analysis

Canton Strategic Holdings (CNTN) Cash & Equivalents (2020 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 7 years of Cash & Equivalents data on file, last reported at $41.5 million in Q1 2026.

  • Quarterly Cash & Equivalents rose 3760.12% year-over-year to $41.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41.5 million (up 3760.12% YoY) and the FY2025 annual result came in at $17.0 million, up 378.53% from the prior year.
  • Cash & Equivalents advanced to $41.5 million in Q1 2026, from $17.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $41.5 million in Q1 2026 to a low of $1.1 million in Q1 2025.
  • A 5-year average of $8.8 million and a median of $7.6 million in 2022 frame the typical range for Cash & Equivalents.
  • Annual changes were most pronounced in 2022 — Cash & Equivalents surged 149361.29% — and 2025, when it plunged 87.23%.
  • Tracing CNTN's Cash & Equivalents over 5 years: stood at $6.5 million in 2022, then surged by 67.96% to $10.9 million in 2023, then slumped by 67.45% to $3.6 million in 2024, then jumped by 378.53% to $17.0 million in 2025, then jumped by 143.84% to $41.5 million in 2026.
  • The last three Cash & Equivalents figures came in at $41.5 million (Q1 2026), $17.0 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1.72 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 815.44 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.71 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 811.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 544.80 Mn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn - 37.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.24 Mn
Mar 31, 2026 41.53 Mn
Dec 31, 2025 12.01 Mn
Sep 30, 2025 7.61 Mn
Jun 30, 2025 2.24 Mn
Mar 31, 2025 1.08 Mn
Dec 31, 2024 3.56 Mn
Sep 30, 2024 4.77 Mn
Jun 30, 2024 7.90 Mn
Mar 31, 2024 8.43 Mn
Dec 31, 2023 10.94 Mn
Sep 30, 2023 2.69 Mn
Jun 30, 2023 3.90 Mn
Mar 31, 2023 3.57 Mn
Dec 31, 2022 6.51 Mn
Sep 30, 2022 7.60 Mn
Jun 30, 2022 9.48 Mn
Mar 31, 2022 11.12 Mn
Dec 31, 2021 4,356.00
Sep 30, 2021 45,095.00